Sacubitril/valsartan in patients post-left ventricular assist device implant: a single-centre case series

Eur J Heart Fail. 2020 Aug;22(8):1490-1492. doi: 10.1002/ejhf.1873. Epub 2020 Jun 20.

Authors

Varinder K Randhawa¹, Lucianne West², Jacob Luthman¹, Jerry D Estep¹, Edward G Soltesz³, Randall C Starling¹

Affiliations

¹ Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.
² Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA.
³ Department of Thoracic and Cardiovascular Surgery, Kaufman Center for Heart Failure, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

PMID: 32562596
DOI: 10.1002/ejhf.1873

No abstract available

Publication types

Letter

MeSH terms

Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Drug Combinations
Heart Failure*
Heart-Assist Devices*
Humans
Stroke Volume
Valsartan

Substances

Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Drug Combinations
Valsartan
sacubitril and valsartan sodium hydrate drug combination